<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=1972889" created="21/11/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>1972889</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Stimulation of the <term id="T1" lex="human_immunodeficiency_virus_type_2_(HIV-2)_gene_expression" sem="Other"><term id="T2" lex="human_immunodeficiency_virus_type_2" sem="Virus">human immunodeficiency virus type 2</term> (<term id="A4" sem="DNA_domain_or_region"><term id="T3" lex="HIV-2" sem="Virus">HIV-2</term>) gene</term> expression</term> by the <term id="A1" sem="DNA_domain_or_region"><term id="T4" lex="cytomegalovirus" sem="Virus">cytomegalovirus</term></term> and <term id="T5" lex="HIV-2_transactivator_gene" sem="DNA_domain_or_region"><term id="T6" lex="HIV-2" sem="Virus">HIV-2</term> <term id="A2" sem="DNA_domain_or_region">transactivator gene</term></term>.</sentence>
<event KT="Investigation" id="E1">
<type class="Positive_regulation"/>
<theme idref="E3"/>
<cause idref="A1" idref1="A2"/>
<clue><clueType>Stimulation</clueType> of the human immunodeficiency virus type 2 (HIV-2) gene expression <linkCause>by</linkCause> the cytomegalovirus and HIV-2 transactivator gene.</clue>
</event>
<event KT="Investigation" id="E2">
<type class="Positive_regulation"/>
<theme idref="E3"/>
<cause idref="T5"/>
<clue><clueType>Stimulation</clueType> of the human immunodeficiency virus type 2 (HIV-2) gene expression <linkCause>by</linkCause> the cytomegalovirus and HIV-2 transactivator gene.</clue>
</event>
<event KT="Other" id="E3">
<type class="Gene_expression"/>
<theme idref="A4"/>
<clue>Stimulation of the human immunodeficiency virus type 2 (HIV-2) gene <clueType>expression</clueType> by the cytomegalovirus and HIV-2 transactivator gene.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="T7" lex="human_immunodeficiency_virus" sem="Virus">Human immunodeficiency virus</term> (<term id="T8" lex="HIV" sem="Virus">HIV</term>) often causes latent infection.</sentence>
<event KT="Fact" id="E4">
<type class="Viral_life_cycle"/>
<theme idref="T8"/>
<clue>Human immunodeficiency virus (HIV) often <clueType>causes latent infection</clueType>.</clue>
</event>
<sentence id="S3">Transactivation by some <term id="T9" lex="DNA_virus" sem="Virus">DNA viruses</term> has been implicated in inducing <term id="T10" lex="HIV-1_replication" sem="Other"><term id="A3" sem="Virus">HIV-1</term> replication</term> and pathogenesis.</sentence>
<event KT="Other" id="E5">
<type class="Positive_regulation"/>
<cause idref="T9"/>
<clue><clueType>Transactivation</clueType> <linkCause>by</linkCause> some DNA viruses has been implicated in inducing HIV-1 replication and pathogenesis.</clue>
<comment>NO THEME</comment></event>
<event KT="Analysis" Source="Other" id="E17">
<type class="Regulation"/>
<theme idref="E6"/>
<cause idref="E5"/>
<clue>Transactivation by some DNA viruses <clueSource>has been</clueSource> <clueType><clueKT>implicated</clueKT></clueType> <linkTheme>in</linkTheme> inducing HIV-1 replication and pathogenesis.</clue>
</event>
<event KT="Analysis" Source="Other" id="E33">
<type class="Regulation"/>
<theme idref="E7"/>
<cause idref="E5"/>
<clue>Transactivation by some DNA viruses <clueSource>has been</clueSource> <clueType><clueKT>implicated</clueKT></clueType> <linkTheme>in</linkTheme> inducing HIV-1 replication and pathogenesis.</clue>
</event>
<event KT="Other" id="E6">
<type class="Positive_regulation"/>
<theme idref="E8"/>
<clue>Transactivation by some DNA viruses has been implicated in <clueType>inducing</clueType> HIV-1 replication and pathogenesis.</clue>
</event>
<event KT="Other" id="E7">
<type class="Positive_regulation"/>
<theme idref="E9"/>
<clue>Transactivation by some DNA viruses has been implicated in <clueType>inducing</clueType> HIV-1 replication and pathogenesis.</clue>
</event>
<event KT="Other" id="E8">
<type class="Viral_life_cycle"/>
<theme idref="A3"/>
<clue>Transactivation by some DNA viruses has been implicated in inducing HIV-1 <clueType>replication</clueType> and pathogenesis.</clue>
</event>
<event KT="Other" id="E9">
<type class="Viral_life_cycle"/>
<theme idref="A3"/>
<clue>Transactivation by some DNA viruses has been implicated in inducing HIV-1 replication and <clueType>pathogenesis</clueType>.</clue>
</event>
<sentence id="S4">The <term id="T11" lex="transactivator_(IE-2)_gene" sem="DNA_domain_or_region">transactivator (IE-2) gene</term> of the human <term id="T12" lex="cytomegalovirus" sem="Virus">cytomegalovirus</term> (<term id="T13" lex="CMV" sem="Virus">CMV</term>) can enhance <cons id="C1" lex="(AS_WELL_AS HIV-2_gene_expression HIV-2_gene_expression)" sem="(AS_WELL_AS Other Other)"><frag id="F1"><term id="T14" lex="HIV-2" sem="Virus">HIV-2</term></frag> as well as <frag id="F2"><term id="T15" lex="HIV-1" sem="Virus">HIV-1</term></frag> <frag id="F3">gene</frag> <frag id="F4">expression</frag></cons> in vitro.</sentence>
<event CL="L2" KT="Analysis" id="E10">
<type class="Positive_regulation"/>
<theme idref="E12"/>
<cause idref="T11"/>
<clue>The transactivator (IE-2) gene of the human cytomegalovirus (CMV) <clueKT><clueCL>can</clueCL></clueKT> <clueType>enhance</clueType> HIV-2 as well as HIV-1 gene expression in vitro.</clue>
</event>
<event CL="L2" KT="Analysis" id="E11">
<type class="Positive_regulation"/>
<theme idref="E13"/>
<cause idref="T11"/>
<clue>The transactivator (IE-2) gene of the human cytomegalovirus (CMV) <clueKT><clueCL>can</clueCL></clueKT> <clueType>enhance</clueType> HIV-2 as well as HIV-1 gene expression in vitro.</clue>
</event>
<event KT="Other" id="E12">
<type class="Gene_expression"/>
<theme idref="T14"/>
<clue>The transactivator (IE-2) gene of the human cytomegalovirus (CMV) can enhance HIV-2 as well as HIV-1 <clueType>gene expression</clueType> in vitro.</clue>
</event>
<event KT="Other" id="E13">
<type class="Gene_expression"/>
<theme idref="T15"/>
<clue>The transactivator (IE-2) gene of the human cytomegalovirus (CMV) can enhance HIV-2 as well as HIV-1 <clueType>gene expression</clueType> in vitro.</clue>
</event>
<sentence id="S5">This inducer can act in concert with the <term id="T17" lex="HIV-2_tat_gene" sem="DNA_domain_or_region"><term id="T18" lex="HIV-2" sem="Virus">HIV-2</term> tat gene</term> and <term id="T19" lex="T-cell_activation" sem="Other"><term id="A9" sem="Cell_natural">T-cell</term> activation</term> in enhancing <term id="A8" sem="Other">gene expression</term> in <term id="T20" lex="human_CD4+_lymphocyte" sem="Cell_natural">human CD4+ lymphocytes</term>.</sentence>
<event CL="L2" KT="Analysis" id="E14">
<type class="Positive_regulation"/>
<theme idref="A8"/>
<cause idref="T11"/>
<cause idref="T17"/>
<clue><corefCause>This inducer</corefCause> <clueKT><clueCL>can</clueCL></clueKT> <clueType>act</clueType> <linkCause>in concert with</linkCause> the HIV-2 tat gene and T-cell activation <clueType>in enhancing</clueType> gene expression <clueLoc>in human CD4+ lymphocytes</clueLoc>.</clue>
</event>
<event CL="L2" KT="Analysis" id="E15">
<type class="Positive_regulation"/>
<theme idref="A8"/>
<cause idref="T11"/>
<cause idref="E16"/>
<clue><corefCause>This inducer</corefCause> <clueKT><clueCL>can</clueCL></clueKT> <clueType>act</clueType> <linkCause>in concert with</linkCause> the HIV-2 tat gene and T-cell activation <clueType>in enhancing</clueType> gene expression <clueLoc>in human CD4+ lymphocytes</clueLoc>.</clue>
</event>
<event KT="Other" id="E16">
<type class="Physiological_process"/>
<theme idref="A9"/>
<clue>This inducer can act in concert with the HIV-2 tat gene and T-cell <clueType>activation</clueType> in enhancing gene expression in human CD4+ lymphocytes.</clue>
</event>
<sentence id="S6">While the <term id="A10" sem="DNA_domain_or_region"><term id="T21" lex="HIV-2" sem="Virus">HIV-2</term></term> and <term id="T22" lex="HIV-1_tat_gene" sem="DNA_family_or_group"><term id="T23" lex="HIV-1" sem="Virus">HIV-1</term> <term id="A11" sem="DNA_domain_or_region">tat genes</term></term> and <term id="T24" lex="T-cell_activator" sem="Protein_family_or_group">T-cell activators</term> apparently employ independent modes of action, the <term id="T25" lex="CMV_transactivator" sem="DNA_domain_or_region">CMV transactivator</term> in combination with the <term id="T26" lex="HIV-2_tat" sem="DNA_domain_or_region"><term id="T27" lex="HIV-2" sem="Virus">HIV-2</term> tat</term> or <term id="T28" lex="T-cell_activator" sem="DNA_family_or_group">T-cell activators</term> may employ a <term id="T29" lex="gene_activation_pathway" sem="Other">gene activation pathway</term> with some common and some distinct components.</sentence>
<event CL="L2" KT="Analysis" Polarity="Negative" assertion="non-exist" id="E18">
<type class="Correlation"/>
<theme idref="A10" idref1="A11"/>
<theme idref="T24"/>
<clue>While the HIV-2 and HIV-1 tat genes and T-cell activators <clueKT><clueCL>apparently</clueCL></clueKT> <clueType>employ <cluePolarity>independent</cluePolarity> modes of action</clueType>, the CMV transactivator in combination with the HIV-2 tat or T-cell activators may employ a gene activation pathway with some common and some distinct components.</clue>
</event>
<event CL="L2" KT="Analysis" Polarity="Negative" assertion="non-exist" id="E19">
<type class="Correlation"/>
<theme idref="A10" idref1="A11"/>
<theme idref="T24"/>
<clue>While the HIV-2 and HIV-1 tat genes and T-cell activators <clueKT><clueCL>apparently</clueCL></clueKT> <clueType>employ <cluePolarity>independent</cluePolarity> modes of action</clueType>, the CMV transactivator in combination with the HIV-2 tat or T-cell activators may employ a gene activation pathway with some common and some distinct components.</clue>
</event>
<event CL="L1" KT="Analysis" id="E20">
<type class="Positive_regulation"/>
<theme idref="T29"/>
<cause idref="T25"/>
<cause idref="T26"/>
<clue>While the HIV-2 and HIV-1 tat genes and T-cell activators apparently employ independent modes of action, the CMV transactivator <linkCause>in combination with</linkCause> the HIV-2 tat or T-cell activators <clueKT><clueCL>may</clueCL></clueKT> <clueType>employ</clueType> a gene activation pathway with some common and some distinct components.</clue>
</event>
<event CL="L1" KT="Analysis" id="E21">
<type class="Positive_regulation"/>
<theme idref="T29"/>
<cause idref="T25"/>
<cause idref="T28"/>
<clue>While the HIV-2 and HIV-1 tat genes and T-cell activators apparently employ independent modes of action, the CMV transactivator <linkCause>in combination with</linkCause> the HIV-2 tat or T-cell activators <clueKT><clueCL>may</clueCL></clueKT> <clueType>employ</clueType> a gene activation pathway with some common and some distinct components.</clue>
</event>
<sentence id="S7">Both <term id="A14" sem="DNA_domain_or_region"><term id="T30" lex="HIV-2" sem="Virus">HIV-2</term></term> and <term id="T31" lex="CMV_transactivator" sem="DNA_domain_or_region">CMV <term id="T32" lex="transactivator" sem="DNA_domain_or_region">transactivators</term></term> enhance <term id="T33" lex="HIV-2_gene_expression" sem="Other"><term id="A13" sem="DNA_domain_or_region"><term id="T34" lex="HIV-2" sem="Virus">HIV-2</term> gene</term> expression</term> by <term id="T35" lex="transcriptional_activation" sem="Other">transcriptional activation</term> involving <cons id="C2" lex="(AS_WELL_AS transcript_initiation transcript_elongation)" sem="(AS_WELL_AS Other Other)"><frag id="F5">transcript</frag> <frag id="F6">initiation</frag> as well as <frag id="F7">elongation</frag></cons>, with <term id="T38" lex="CMV_transactivator" sem="DNA_domain_or_region">CMV <term id="T39" lex="transactivator" sem="Protein_family_or_group">transactivator</term></term> affecting <term id="T40" lex="elongation" sem="Other">elongation</term> more than the <term id="T41" lex="initiationp" sem="Other">initiation</term>.</sentence>
<event id="E22">
<type class="Positive_regulation"/>
<theme idref="E24"/>
<cause idref="E25"/>
<clue>Both HIV-2 and CMV transactivators <clueType>enhance</clueType> HIV-2 gene expression <linkCause>by</linkCause> transcriptional activation involving transcript initiation as well as elongation, with CMV transactivator affecting elongation more than the initiation.</clue>
</event>
<event id="E36">
<type class="Positive_regulation"/>
<theme idref="E24"/>
<cause idref="E26"/>
<clue>Both HIV-2 and CMV transactivators <clueType>enhance</clueType> HIV-2 gene expression <linkCause>by</linkCause> transcriptional activation involving transcript initiation as well as elongation, with CMV transactivator affecting elongation more than the initiation.</clue>
</event>
<event id="E23">
<type class="Positive_regulation"/>
<theme idref="E24"/>
<cause idref="E27"/>
<clue>Both HIV-2 and CMV transactivators <clueType>enhance</clueType> HIV-2 gene expression <linkCause>by</linkCause> transcriptional activation involving transcript initiation as well as elongation, with CMV transactivator affecting elongation more than the initiation.</clue>
</event>
<event id="E29">
<type class="Positive_regulation"/>
<theme idref="E24"/>
<cause idref="E28"/>
<clue>Both HIV-2 and CMV transactivators <clueType>enhance</clueType> HIV-2 gene expression <linkCause>by</linkCause> transcriptional activation involving transcript initiation as well as elongation, with CMV transactivator affecting elongation more than the initiation.</clue>
</event>
<event id="E24">
<type class="Gene_expression"/>
<theme idref="A13"/>
<clue>Both HIV-2 and CMV transactivators enhance HIV-2 gene <clueType>expression</clueType> by transcriptional activation involving transcript initiation as well as elongation, with CMV transactivator affecting elongation more than the initiation.</clue>
</event>
<event id="E25">
<type class="Positive_regulation"/>
<theme idref="F5" idref1="F6"/>
<cause idref="A14" idref1="T32"/>
<clue>Both HIV-2 and CMV transactivators enhance HIV-2 gene expression by <corefTheme>transcriptional activation</corefTheme> involving transcript initiation as well as elongation, with CMV transactivator affecting elongation more than the initiation.</clue>
<comment>NO CLUETYPE; NER: T32 sem mod, Protein_family_or_group -&gt; DNA_domain_or_region</comment></event>
<event id="E26">
<type class="Positive_regulation"/>
<theme idref="F5" idref1="F7"/>
<cause idref="A14" idref1="T32"/>
<clue>Both HIV-2 and CMV transactivators enhance HIV-2 gene expression by <corefTheme>transcriptional activation</corefTheme> involving transcript initiation as well as elongation, with CMV transactivator affecting elongation more than the initiation.</clue>
<comment>NO CLUETYPE; NER: T32 sem mod, Protein_family_or_group -&gt; DNA_domain_or_region</comment></event>
<event id="E27">
<type class="Positive_regulation"/>
<theme idref="F5" idref1="F6"/>
<cause idref="T31"/>
<clue>Both HIV-2 and CMV transactivators enhance HIV-2 gene expression by <corefTheme>transcriptional activation</corefTheme> involving transcript initiation as well as elongation, with CMV transactivator affecting elongation more than the initiation.</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E28">
<type class="Positive_regulation"/>
<theme idref="F5" idref1="F7"/>
<cause idref="T31"/>
<clue>Both HIV-2 and CMV transactivators enhance HIV-2 gene expression by <corefTheme>transcriptional activation</corefTheme> involving transcript initiation as well as elongation, with CMV transactivator affecting elongation more than the initiation.</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E30">
<type class="Regulation"/>
<theme idref="T40"/>
<cause idref="T38"/>
<clue>Both HIV-2 and CMV transactivators enhance HIV-2 gene expression by transcriptional activation involving transcript initiation as well as elongation, with CMV transactivator <clueType>affecting</clueType> elongation more than the initiation.</clue>
<comment>NER: T35, T36 del &quot;transcript initiation&quot;&quot;elongation&quot;</comment></event>
<event id="E31">
<type class="Regulation"/>
<theme idref="T41"/>
<cause idref="T38"/>
<clue>Both HIV-2 and CMV transactivators enhance HIV-2 gene expression by transcriptional activation involving transcript initiation as well as elongation, with CMV transactivator <clueType>affecting</clueType> elongation more than the initiation.</clue>
</event>
<sentence id="S8">A significant proportion of <term id="T42" lex="transcript" sem="RNA_family_or_group">transcripts</term> appear to terminate prematurely in the absence of <term id="T43" lex="transactivator" sem="Protein_family_or_group">transactivators</term>.</sentence>
<event CL="L2" KT="Analysis" Polarity="Negative" assertion="non-exist" id="E32" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="T42"/>
<cause idref="T43"/>
<clue>A significant proportion of transcripts <clueKT><clueCL>appear</clueCL></clueKT> to <clueType>terminate prematurely</clueType> <linkCause><cluePolarity>in the absence of</cluePolarity></linkCause> transactivators.</clue>
</event>
<sentence id="S9"><term id="T44" lex="deletion_mutation_analysis" sem="Other">Deletion mutation analysis</term> of the <term id="T45" lex="HIV-2_long_terminal_repeat" sem="DNA_domain_or_region"><term id="T46" lex="HIV-2" sem="Virus">HIV-2</term> long terminal repeat</term> (<term id="T47" lex="LTR" sem="DNA_domain_or_region">LTR</term>) suggests that the <term id="A16" sem="DNA_domain_or_region">element</term> that responds to <term id="T48" lex="CMV_transactivation" sem="Other"><term id="T49" lex="CMV" sem="Virus">CMV</term> transactivation</term> in <term id="T50" lex="human_CD4+_lymphocyte" sem="Cell_natural">human CD4+ lymphocytes</term> is either a diffuse one or located downstream of the <term id="T51" lex="HIV-2_enhancer_element" sem="DNA_domain_or_region"><term id="T52" lex="HIV-2" sem="Virus">HIV-2</term> enhancer element</term>.</sentence>
<event KT="Other" id="E35">
<type class="Regulation"/>
<theme idref="A16"/>
<cause idref="E34"/>
<clue><clueExperiment>Deletion mutation analysis of the HIV-2 long terminal repeat (LTR)</clueExperiment> suggests that the element that <clueType>responds</clueType> <linkCause>to</linkCause> CMV transactivation in human CD4+ lymphocytes is either a diffuse one or located downstream of the HIV-2 enhancer element.</clue>
</event>
<event KT="Other" id="E34">
<type class="Positive_regulation"/>
<cause idref="T49"/>
<clue>Deletion mutation analysis of the HIV-2 long terminal repeat (LTR) suggests that the element that responds to CMV <clueType>transactivation</clueType> <clueLoc>in human CD4+ lymphocytes</clueLoc> is either a diffuse one or located downstream of the HIV-2 enhancer element.</clue>
<comment>NO THEME</comment></event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
